FY2027 EPS Estimates for Cytokinetics, Incorporated (NASDAQ:CYTK) Lowered by Leerink Partnrs
Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) – Investment analysts at Leerink Partnrs cut their FY2027 earnings per share (EPS) estimates for Cytokinetics in a research note issued on Wednesday, May 22nd. Leerink Partnrs analyst R. Ruiz now forecasts that the biopharmaceutical company will post earnings per share of $3.85 for the year, down from their […]
More Stories
Otsuka Holdings Co., Ltd. (OTCMKTS:OTSKY) Sees Large Increase in Short Interest
Otsuka Holdings Co., Ltd. (OTCMKTS:OTSKY – Get Free Report) saw a significant growth in short interest in September. As of...
BTCS Inc. (NASDAQ:BTCS) Short Interest Update
BTCS Inc. (NASDAQ:BTCS – Get Free Report) was the target of a large decline in short interest in September. As...
CHS Inc. (NASDAQ:CHSCP) Sees Significant Growth in Short Interest
CHS Inc. (NASDAQ:CHSCP – Get Free Report) saw a significant increase in short interest in the month of September. As...
Pinnacle Bank (OTCMKTS:PBNK) Short Interest Update
Pinnacle Bank (OTCMKTS:PBNK – Get Free Report) was the target of a large decline in short interest in September. As...
Lantern Pharma Inc. (NASDAQ:LTRN) Short Interest Down 19.8% in September
Lantern Pharma Inc. (NASDAQ:LTRN – Get Free Report) saw a large decrease in short interest in September. As of September...
Mobico Group Plc (OTCMKTS:NXPGF) Sees Significant Decline in Short Interest
Mobico Group Plc (OTCMKTS:NXPGF – Get Free Report) saw a large drop in short interest in the month of September....